Sarepta Therapeutics Inc Congressional Trading
According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 18 trades in Sarepta Therapeutics Inc (NASDAQ: SRPT) since 2012, across 4 members, worth an estimated $217.51K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 11 buys against 7 sells, a modestly buy-led skew, with Democratic members responsible for 94% of the trades and Republican members 6%. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. Sarepta Therapeutics Inc's current Quantellect Tide Score is 48 out of 100 (Calm Tide), Bottom 48% of universe (3876); the Tide Score is generated algorithmically from public filings and market data and is not investment advice. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Sarepta Therapeutics Inc (SRPT) stock overview and the complete trade table below.
Price & congressional trade timeline
Party breakdown
Sarepta Therapeutics congressional trading activity
| Politician | Published | Traded | Filed After | Type | Size | Return | Owner | |
|---|---|---|---|---|---|---|---|---|
| No congressional trades in this period. | ||||||||
Sarepta Therapeutics (SRPT) congressional trading FAQ
Can members of Congress legally trade Sarepta Therapeutics (SRPT) stock?
Yes. Members of Congress are permitted to trade individual stocks, including Sarepta Therapeutics (SRPT), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; it does not imply any trade was improper.
Are congressional Sarepta Therapeutics (SRPT) trades public?
Yes. Every congressional trade in Sarepta Therapeutics (SRPT) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.
How many times has Congress traded Sarepta Therapeutics (SRPT)?
Members of Congress have disclosed 18 trades in Sarepta Therapeutics (SRPT) worth $217.51K across 4 members, according to public STOCK Act filings.
Do Democrats or Republicans trade Sarepta Therapeutics (SRPT) more?
Across disclosed Sarepta Therapeutics (SRPT) trades, 94% were by Democrats and 6% by Republicans, led by Democrats (94%).
What is Sarepta Therapeutics (SRPT)'s Tide Score?
Sarepta Therapeutics (SRPT) has a Quantellect Tide Score of 48 (Calm Tide). The Tide Score is a 0-100 read blending price forecast, smart-money flow, technicals, and social sentiment; higher is more bullish.
Browse all stocks Congress tradesCongressional trading overviewSarepta Therapeutics (SRPT) stock overview
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.